Talking Points & Analysis of President Donald J. Trump Executive Order: LOWERING  DRUG PRICES BY ONCE AGAIN PUTTING AMERICANS FIRST ...

Whenever lawmakers begin discussing Pharmacy Benefit Manager (PBM) reform, a familiar pattern emerges: new advocacy groups, often with...

It’s happening again. Independent pharmacies across the country are receiving notices that their pharmacy software is being phased out....

Pharmacy benefit managers (PBMs) and their lobbyists have mastered the art of spin. They claim to lower drug prices, increase patient...

Recently the Texas Attorney General (AG) issued an opinion on state House Bills 1763 and 1919. This opinion has significant implications for the regulation of pharmacy benefit managers (PBMs) in Texas. AG Paxton’s opinion addresses the enforceability of these laws and their interaction with federal regulations, specifically the Employee Retirement Income Security Act (ERISA). Why Does It Matter? An AG’s opinion is an authoritative interpretation of existing laws requested by

Author: Brandi Chane, PUTT Executive Board member In the Fall of 2024 we had the opportunity to attend the PDAB Patient Advocacy Summit...

This week American Pharmacy Cooperative, Inc. (APCI) took a bold step  in the ongoing campaign for PBM reform: they openly called on Vanguard Inc., the largest investor of in the parent companies of the “Big 3” pharmacy benefit managers (PBMs), to use its influence to curtail their PBMs’ abuse of patients and pharmacies.  “As one of the largest investors in United Healthcare, CVS, and Cigna, Vanguard is in a unique position to help effectuate real and meaningful change on beh